D-methionine (D-met) significantly reduces kanamycin-induced ototoxicity in pigmented guinea pigs

References

• Begg E. & Barclay M. 1995. Aminoglycoside – 50 years on. Br J Clin Pharmacol, 39, 597–596.3.
   PubMed Web of Science ®Google Scholar
• Bock G.R., Yates G.K., Miller J.J. & Moorjani P. 1983. Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear Res, 9, 255–262.
   PubMed Web of Science ®Google Scholar
• Campbell K.C.M., Rybak L.P., Meech R.P. & Hughes L. 1996. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res, 102, 90
   PubMed Web of Science ®Google Scholar
• Campbell K.C.M., Meech R.P., Rybak L.P. & Hughes L.F. 1999. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res, 138, 13–28.
   PubMed Web of Science ®Google Scholar
• Campbell K.C.M., Meech R.P., Klemens J.J., Gerberi M.T., Dyrstad S.W. et al. 2007. Prevention of noise- and drug-induced hearing loss with D-methionine. Hear Res, 226, 92–103.
   PubMed Web of Science ®Google Scholar
• Campbell K., Claussen A., Meech R., Verhulst S., Fox D. et al. 2011. D-methionine (D-met) significantly rescues noise-induced hearing loss: Timing studies. Hear Res, 282, 138–144.
   PubMed Web of Science ®Google Scholar
• Claussen A., Fox D., Yu X., Meech R., Verhulst S. et al. 2013. D-methionine pre-loading reduces both noise-induced permanent threshold shift and outer hair cell loss in the chinchilla. Int J Audiol, 52, 801–807.
   PubMed Web of Science ®Google Scholar
• Clifford R.E., Coleman J.K., Balough B.J., Liu J. & Kopke R.D. 2011. Low-dose D-methionine and N-acetyl-L-cysteine for protection from permanent noise-induced hearing loss in chinchillas. Otolaryngol Head Neck Surg, 145, 999–1006.
   PubMed Web of Science ®Google Scholar
• Eldredge D., Miller J. & Bohne B. 1981. A frequency-position map for the chinchilla cochlea. J Acoust Soc Am, 69, 109–1095.
   Google Scholar
• Forge A. & Schacht J. 2000. Aminoglycoside antibiotics. Audiol Neurootol, 5, 3–22.
   PubMed Web of Science ®Google Scholar
• Fox D., Cooper M., Speil C., Roberts M., Yanik S.,. et al. 2015. D-methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models. J Cystic Fibrosis, In Press. DOI: 10.1016/j.jcf.2015.06.005.
   PubMedGoogle Scholar
• Greenwood G. 1959. Neomycin ototoxicity; report of a case. AMA Arch Otolaryngol, 69(4), 390–397.
   PubMedGoogle Scholar
• Harris T., Bardien S., Schaaf H.S., Petersen L., Jong G. et al. 2012. Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients. S Afr Med J, 102, 363–366.
   PubMed Web of Science ®Google Scholar
• Hock R. & Anderson R. 1995. Prevention of drug-induced nephrotoxicity in the intensive care unit. J Crit Care, 10, 33–43.
   PubMed Web of Science ®Google Scholar
• Klastersky J., Nyamubeya B. & Vandenborre L. 1974. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.. J Med Microbiol, 7, 465–472.
   PubMed Web of Science ®Google Scholar
• Korver K.D., Rybak L.P., Whitworth C.A. & Campbell K.C.M. 2002. Round window application of D-methionine provides complete cisplatin otoprotection. - Otolaryngol Head Neck Surg, 126, 683–689.
   PubMed Web of Science ®Google Scholar
• Lecca G., Terry J., Maggiolo L. & Morales A. 1959. Ototoxicity of kanamycin; report of three cases. J Am Med Assoc, 170, 2064–2068.
   PubMed Web of Science ®Google Scholar
• Lu S.C. 1998. Regulation of hepatic glutathione synthesis: current concepts and controversies. Faseb J, 13, 1169–1183.
   Web of Science ®Google Scholar
• Matz G.J. 1993. Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am, 26, 705–712.
   PubMed Web of Science ®Google Scholar
• Meyer R.D. 1986. Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med, 80, 119–125.
   PubMed Web of Science ®Google Scholar
• Naunton R.F. & Ward P.H. 1959. The ototoxicity of Kanamycin sulfate in the presence of compromised renal function. AMA Arch Otolaryngol, 69, 398–399.
   PubMedGoogle Scholar
• Parry M.F. & Neu H.C. 1977. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol, 5, 58–61.
   PubMed Web of Science ®Google Scholar
• Pandya A. 2014. Nonsyndromic hearing loss and deafness, mitochondrial. In GeneReviews [Internet]. Seattle, WA. University of Washington, Seattle; 1993–2016.
   Google Scholar
• Peloquin C.A., Berning S.E., Nitta A.T., Simone P.M., Goble M. et al. 2004. Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis, 38, 1538–1544.
   PubMed Web of Science ®Google Scholar
• Peterson L. & Rogers C. 2015. Aminoglycoside-induced hearing deficits- a review of cochlear ototoxicity. South African Family Practice, 57, 77–82.
   Web of Science ®Google Scholar
• Polony G., Humli V., Ando R., Aller M., Horvaith T., Hamos A., Tamas L., Vizi E., Zelles T. 2014. Protective effect of rasagiline in aminoglycoside ototoxicity. Neuroscience. Apr.: 18(265), 263–73.
   Web of Science ®Google Scholar
• Schacht J., Talaska A. & Rybak L. 2012. Cisplatin and aminoglycoside antibiotics: Hearing loss and its prevention. Anat Rec (Hoboken), 295(11), 1837–1850.
   PubMedGoogle Scholar
• Sha S.H. & Schacht J. 2000. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res, 142, 34–40.
   PubMed Web of Science ®Google Scholar
• Song B.B., Sha S.H. & Schacht J. 1998. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. Free Radic Biol Med, 25, 189–195.
   PubMed Web of Science ®Google Scholar
• Terril L. & Clemons D. 1997. The Laboratory Guinea Pig. Boca Raton (FL): CRC Press.
   Google Scholar
• Vogt W. 1995. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med, 18, 93–105.
   PubMed Web of Science ®Google Scholar